INS and Hypoglycemia: Consideration should be given to risk of hypoglycaemia with, for example, longer-acting insulin analogues (glargine and detemir) being preferable to intermediate-acting human insulin [neutral protamine Hagedorn (NPH)], as they are associated with reduced risk of hypoglycaemia (20–25), including nocturnal hypoglycaemia (24).